Broach James

Avg. Two Year Performance

(33%) Avg. Purchase Return
(15%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(3%)(3%)(8%)(9%)(33%)
Purchase Success Rate0 of 10 of 10 of 10 of 10 of 1
Average Sale Return----------
Sale Success Rate----------

Cadus Corp.

Drugs » Biotechnology

Director:

Holdings: 3.3K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--